471 related articles for article (PubMed ID: 26531137)
1. Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).
Huai G; Qi P; Yang H; Wang Y
Int J Mol Med; 2016 Jan; 37(1):11-20. PubMed ID: 26531137
[TBL] [Abstract][Full Text] [Related]
2. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.
Galili U
Immunol Cell Biol; 2005 Dec; 83(6):674-86. PubMed ID: 16266320
[TBL] [Abstract][Full Text] [Related]
3. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates.
Galili U
Xenotransplantation; 2013; 20(5):267-76. PubMed ID: 23968556
[TBL] [Abstract][Full Text] [Related]
4. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
5. Significance of the evolutionary α1,3-galactosyltransferase (GGTA1) gene inactivation in preventing extinction of apes and old world monkeys.
Galili U
J Mol Evol; 2015 Jan; 80(1):1-9. PubMed ID: 25315716
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy to inhibit xenoantibody production using lentiviral vectors in non-human primates.
Fischer-Lougheed JY; Tarantal AF; Shulkin I; Mitsuhashi N; Kohn DB; Lee CC; Kearns-Jonker M
Gene Ther; 2007 Jan; 14(1):49-57. PubMed ID: 16886002
[TBL] [Abstract][Full Text] [Related]
7. alpha-galactosyl (Galalpha1-3Galbeta1-4GlcNAc-R) epitopes on human cells: synthesis of the epitope on human red cells by recombinant primate alpha1,3galactosyltransferase expressed in E.coli.
Galili U; Anaraki F
Glycobiology; 1995 Dec; 5(8):775-82. PubMed ID: 8720075
[TBL] [Abstract][Full Text] [Related]
8. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
Manches O; Plumas J; Lui G; Chaperot L; Molens JP; Sotto JJ; Bensa JC; Galili U
Haematologica; 2005 May; 90(5):625-34. PubMed ID: 15921377
[TBL] [Abstract][Full Text] [Related]
9. Natural protection from zoonosis by alpha-gal epitopes on virus particles in xenotransmission.
Kim NY; Jung WW; Oh YK; Chun T; Park HY; Lee HT; Han IK; Yang JM; Kim YB
Xenotransplantation; 2007 Mar; 14(2):104-11. PubMed ID: 17381684
[TBL] [Abstract][Full Text] [Related]
10. Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer.
Galili U
Cancer Immunol Immunother; 2004 Nov; 53(11):935-45. PubMed ID: 15205919
[TBL] [Abstract][Full Text] [Related]
11. [Why humans and Catarrhini lack the Galalpha1-3Gal epitope, related to xenograft rejection?].
Suchanowska A; Czerwiński M
Postepy Hig Med Dosw (Online); 2009 Jun; 63():250-7. PubMed ID: 19502686
[TBL] [Abstract][Full Text] [Related]
12. Possible role of a cell surface carbohydrate in evolution of resistance to viral infections in old world primates.
Rodriguez IA; Welsh RM
J Virol; 2013 Aug; 87(15):8317-26. PubMed ID: 23740988
[TBL] [Abstract][Full Text] [Related]
13. Reduction of alpha-galactosyl xenoantigen by expression of endo-beta-galactosidase C in pig endothelial cells.
Ogawa H; Kobayashi T; Yokoyama I; Nagatani N; Mizuno M; Yoshida J; Kadomatsu K; Muramatsu H; Nakao A; Muramatsu T
Xenotransplantation; 2002 Jul; 9(4):290-6. PubMed ID: 12060465
[TBL] [Abstract][Full Text] [Related]
14. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
15. Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits.
Galili U
Immunology; 2013 Sep; 140(1):1-11. PubMed ID: 23578170
[TBL] [Abstract][Full Text] [Related]
16. Anti-Gal antibody-mediated allograft rejection in alpha1,3-galactosyltransferase gene knockout mice: a model of delayed xenograft rejection.
Pearse MJ; Witort E; Mottram P; Han W; Murray-Segal L; Romanella M; Salvaris E; Shinkel TA; Goodman DJ; d'Apice AJ
Transplantation; 1998 Sep; 66(6):748-54. PubMed ID: 9771838
[TBL] [Abstract][Full Text] [Related]
17. First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses.
Naso F; Gandaglia A; Bottio T; Tarzia V; Nottle MB; d'Apice AJ; Cowan PJ; Cozzi E; Galli C; Lagutina I; Lazzari G; Iop L; Spina M; Gerosa G
Xenotransplantation; 2013; 20(4):252-61. PubMed ID: 23865597
[TBL] [Abstract][Full Text] [Related]
18. Discovery of the natural anti-Gal antibody and its past and future relevance to medicine.
Galili U
Xenotransplantation; 2013; 20(3):138-47. PubMed ID: 23577774
[TBL] [Abstract][Full Text] [Related]
19. Masking and reduction of the Galactose-alpha1,3-Galactose (alpha-Gal) epitope, the major xenoantigen in swine, by the glycosyltransferase gene transfection.
Miyagawa S; Tanemura M; Koyota S; Koma M; Ikeda Y; Shirakura R; Taniguchi N
Biochem Biophys Res Commun; 1999 Nov; 264(3):611-4. PubMed ID: 10543979
[TBL] [Abstract][Full Text] [Related]
20. Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody.
Galili U
Springer Semin Immunopathol; 1993; 15(2-3):155-71. PubMed ID: 7504839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
